Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
This study has been completed.
Study NCT00007527
Information provided by Department of Veterans Affairs
First Received on December 29, 2000.
Last Updated on January 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
